We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Premier Biosoft and MRC-Holland Form Alliance

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Premier Biosoft and MRC-Holland Form Alliance"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Premier Biosoft International and MRC-Holland have announced an alliance. Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method to establish the copy number of up to 45 nucleic acid sequences in a single reaction.

Detecting copy number changes in the genome, the primary application of MLPA® technology, is a widely researched area.

MLPA® probes are able to discriminate between sequences that differ by just one nucleotide, making them a sensitive tool for detecting the changes.

The alliance will help MLPA® users design custom oligos for genes that do not have kits available. Currently, no such design tool exists.

"With this collaboration, both PREMIER Biosoft and MRC-Holland will use their core competencies and expertise to develop a powerful bioinformatics tool for MLPA® users," commented Kay Brown, V.P. Business Development and Marketing.